ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.727,20
0,48%
S&P 500
6.071,17
0,53%
Dow Jones
44.882,13
0,38%
Euro vs US Dollar
1,03939
-0,03%
Bitcoin
104.505,21
-0,22%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. PainReform Ltd (PRFX)

  7. PainReform Ltd (PRFX) News

PRFX

PainReform (PRFX)

PainReform Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PRFX
DatumZeitQuelleÜberschriftSymbolFirma
02/01/202522h15Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PRFXPainReform Ltd
02/01/202522h06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
27/12/202414h58Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
27/12/202414h30GlobeNewswire Inc.PainReform Provides Further Update on Phase 3 Clinical Trial of PRF-110NASDAQ:PRFXPainReform Ltd
13/12/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PRFXPainReform Ltd
12/12/202423h00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRFXPainReform Ltd
06/12/202422h30Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:PRFXPainReform Ltd
04/12/202422h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
20/11/202414h50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
20/11/202414h30GlobeNewswire Inc.PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical TrialNASDAQ:PRFXPainReform Ltd
18/11/202423h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
12/11/202414h02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
07/11/202423h00GlobeNewswire Inc.PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity RequirementNASDAQ:PRFXPainReform Ltd
07/11/202422h59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
04/11/202422h39Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
16/10/202422h35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
16/10/202422h30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PRFXPainReform Ltd
10/10/202423h25Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
04/10/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PRFXPainReform Ltd
30/09/202422h15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
20/09/202422h30Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:PRFXPainReform Ltd
11/09/202415h36Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
11/09/202414h30GlobeNewswire Inc.PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110NASDAQ:PRFXPainReform Ltd
10/09/202415h46GlobeNewswire Inc.PainReform Announces Exercise of Warrants for $1.58 Million Gross ProceedsNASDAQ:PRFXPainReform Ltd
10/09/202415h13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
04/09/202422h16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
30/08/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PRFXPainReform Ltd
28/08/202422h30Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:PRFXPainReform Ltd
27/08/202423h07Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:PRFXPainReform Ltd
26/08/202423h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
 Showing the most relevant articles for your search:NASDAQ:PRFX

Kürzlich von Ihnen besucht

COIN
ADAUSD
Cardano
CCOM
US500
US 500
NYSE
MCD
McDonalds
USOTC
BNPQY
BNP Paribas (QX)
CCOM
US30
US 30
USOTC
ADDYY
Adidas (QX)
NASDAQ
AAPL
Apple
NYSE
NKE
Nike
NYSE
MRK
Merck
NASDAQ
QQQ
Invesco QQQ Trust Series 1
DBI
MDAX
MDAX
DBI
DAX
DAX
FX
EURJPY
Euro vs Yen
CCOM
US100
US Tech 100
AMEX
XLE
Energy Select Sector SPDR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten